Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
5 Must-Attempt Fascinating Dishes from Around the World- Going on a bad date is a drag. Worse? Ending up as a cautionary tale on TikTok.
- Report in relation to renaming Herzog Park set to be withdrawn
- How did humans evolve, and will we evolve more?
- Tragedy in Minnesota, vaccine news, Snoop's game call: Week in review
- The most effective method to Amplify Your Opportunity for growth in a Web-based Degree Program
- Investigating the Medical advantages of Aloe Vera
- SpaceX rocket launches 140 satellites into orbit on Transporter-15, aces landing at sea (video)
- No more attempts to free whale stranded off Germany, officials say
